ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $624,867 | -13.0% | 29,984 | 0.0% | 0.51% | +10.2% |
| Q2 2023 | $718,117 | +27.3% | 29,984 | 0.0% | 0.46% | +19.5% |
| Q1 2023 | $564,299 | +18.2% | 29,984 | 0.0% | 0.38% | +16.7% |
| Q4 2022 | $477,345 | -2.8% | 29,984 | 0.0% | 0.33% | +5.1% |
| Q3 2022 | $491,000 | +16.4% | 29,984 | 0.0% | 0.31% | +7.9% |
| Q2 2022 | $422,000 | -41.9% | 29,984 | 0.0% | 0.29% | -15.7% |
| Q1 2022 | $726,000 | -11.2% | 29,984 | -14.4% | 0.34% | +42.1% |
| Q4 2021 | $818,000 | – | 35,035 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |